Scientists discover how smoking weed has unexpected impact on testosterone levels in young men
#82 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
This finding challenges the long-held clinical assumption that cannabis use suppresses testosterone, which clinicians should consider when counseling young male patients about reproductive health and sexual function. Clinicians need updated guidance on how cannabis affects endocrine function to provide accurate risk-benefit information, particularly for patients already concerned about hormonal changes or fertility. If higher testosterone levels occur in cannabis users, clinicians should investigate potential downstream effects on mood, aggression, cardiovascular health, and prostate function to fully inform patient counseling.
A recent study challenges the widely held assumption that cannabis use suppresses testosterone, instead finding that young men who use cannabis have significantly higher testosterone levels compared to non-users. This counterintuitive finding suggests that the relationship between cannabinoid exposure and endocrine function may be more complex than previously understood, with potential implications for how clinicians counsel patients regarding cannabis use and reproductive or metabolic health. While the cross-sectional design cannot establish causation, the results raise important questions about whether certain individuals may be more prone to cannabis use due to underlying hormonal differences, or whether cannabis itself produces unexpected neuroendocrine effects in young populations. Clinicians should recognize that previous guidance based on assumptions of testosterone suppression may require reconsideration pending additional longitudinal and mechanistic research. The practical takeaway is that clinicians should avoid making assumptions about cannabis’ endocrine effects based on outdated or theoretical models, and instead counsel patients based on current evidence while acknowledging areas of uncertainty in cannabis pharmacology.
“What we’re seeing in the literature is that acute cannabis use may transiently elevate testosterone through sympathomimetic activity, but this doesn’t tell us about chronic effects or what happens in regular users over months and years, and that’s what actually matters for my patients concerned about sexual function and fertility.”
💊 While this counterintuitive finding challenges longstanding assumptions about cannabis and male hormones, clinicians should interpret the results cautiously given the study’s observational design and inability to establish causation. The elevated testosterone observed in cannabis users may reflect confounding by age, body composition, physical activity, or other lifestyle factors rather than a true effect of cannabis itself, and cross-sectional associations do not clarify whether cannabis use increases testosterone, whether higher testosterone predisposes to cannabis use, or whether unmeasured variables explain both. Additionally, acute cannabis effects on testosterone may differ substantially from chronic use patterns, and study populations may not generalize across diverse age groups, dosing regimens, or routes of administration. When counseling young men about cannabis use, providers should acknowledge this emerging data while emphasizing that testosterone level alone is an incomplete marker of sexual or reproductive health, and that cannabis use may still carry risks for motivation, cognitive development, or substance use disorder that
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
